EQA

New schemes

We actively follow the development of laboratory medicine as we want to produce clinically relevant EQA schemes to serve clinical laboratories and point-of-care sites. We launch new pilot studies on a regular basis and aim to increase our EQA portfolio with 5-10 new EQA schemes every year.

See the latest new schemes

Planned pilot studies for 2025

We are planning new EQA pilot studies for 2025. The arranged pilots will be free of charge for a limited number of participants.

 If you registered for one or more pilots through the general registration link earlier this year, we will send you more information as the pilot approaches. This year, we also include a short survey in the pilot studies. By responding, you can give us important information on how we can make the EQA scheme better for you.

This page will be updated as further studies are scheduled.

Recently performed pilot studies

Holotranscobalamin (HoloTC) and Methylmalonic Acid

Check the up-to-date round schedules in the latest product catalogue.

Norovirus, antigen detection

Check the up-to-date round schedules in the latest product catalogue.

Helicobacter pylori, nucleic acid detection

Check the up-to-date round schedules in the latest product catalogue.

Maternal serum screening

Check the up-to-date round schedules in the latest product catalogue.

Mycoplasma genitalium, drug resistance multiplex, nucleic acid detection

Check the up-to-date round schedules in the latest product catalogue.

Pipette control

Check the up-to-date round schedules in the latest product catalogue.

Salivary Cortisol

Check the up-to-date round schedules in the latest product catalogue.

Chemokine CXCL13

Check the up-to-date round schedules in the latest product catalogue.

Interferon Gamma Release Assay (IGRA) for Mycobacterium tuberculosis

Check the up-to-date round schedules in the latest product catalogue.

Faecal Elastase

Check the up-to-date round schedules in the latest product catalogue.

Fungal infections, nucleic acid detection

Check the up-to-date round schedules in the latest product catalogue.

Mycobacterium tuberculosis, rifampicin and isoniazid, nucleic acid detection

Check the up-to-date round schedules in the latest product catalogue.

Adrenocorticothropic hormone ACTH and Cortisol

Check the up-to-date round schedules in the latest product catalogue.

HSV1&2 / VZV / T. pallidum, nucleic acid detection

Check the up-to-date round schedules in the latest product catalogue.

EQA for next-generation sequencing methods

We are developing external quality assessments for NGS methods in microbiology. If you are interested, please contact us!

Contact us for more information!

Heidi Berghäll

EQA Solutions Manager, R&D

heidi.berghall@labquality.com

Kristel Virtanen

Kristel Virtanen

EQA Solutions Manager, IT

kristel.virtanen@labquality.com

Related Services

EQA

EQA Programme 2023

Labquality’s external quality assessment program (EQAS) is aimed at medical laboratories and point-of-care testing sites.

External Quality Assessment

EQA

External Quality Assessment

Our EQA schemes are designed for medical laboratories and point-of-care testing sites to monitor and improve their performance.

Integrated EQA Service

EQA

Integrated EQA Service

Integrated EQA service is a completely new approach to external quality assessment.

Labquality’s Partners in EQA

EQA

Labquality’s Partners in EQA

Labquality has EQA partners in more than 40 countries in Europe, South America, South-East Asia and the Middle East. Please find the contact details here.

External Quality Assessment Services

EQA

External Quality Assessment Services

Our external quality assessment service programme includes more than 160 EQA schemes, covering the key specialities of laboratory medicine.

EQAS for preanalytical phase

EQA

EQAS for preanalytical phase

Labquality’s preanalytical external quality assessment schemes provide a unique means to assess a larger part of the total laboratory testing cycle.